Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 15, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Conformal Medical this week reported "encouraging" results for its left atrial appendage occlusion device. Fast Five hosts Danielle Kirsh and Sean Whooley discuss what the device does and what doctors think about the device.
Autonomix has completed its first procedures in its pancreatic cancer ablation trial. Learn what the trial will assess, what the technology does and how optimistic executives are.
Axonics won CE mark approval for its fourth-generation rechargeable sacral neuromodulation system. Whooley talks about what the device does and some of the other news Axonics has had recently.
SafeGuard Surgical won an FDA breakthrough nod for its biodegradable stent. Hear more about the stent, which has backing from an NFL quarterback.
Edwards reported "excellent" outcomes with its latest Sapien TAVR study. The Fast Five hosts talk about some of the data points that stuck out.
All content for Fast Five Medtech News Podcast is the property of MassDevice and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 15, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Conformal Medical this week reported "encouraging" results for its left atrial appendage occlusion device. Fast Five hosts Danielle Kirsh and Sean Whooley discuss what the device does and what doctors think about the device.
Autonomix has completed its first procedures in its pancreatic cancer ablation trial. Learn what the trial will assess, what the technology does and how optimistic executives are.
Axonics won CE mark approval for its fourth-generation rechargeable sacral neuromodulation system. Whooley talks about what the device does and some of the other news Axonics has had recently.
SafeGuard Surgical won an FDA breakthrough nod for its biodegradable stent. Hear more about the stent, which has backing from an NFL quarterback.
Edwards reported "excellent" outcomes with its latest Sapien TAVR study. The Fast Five hosts talk about some of the data points that stuck out.
Former Stimwave CEO convicted of healthcare fraud; GE HealthCare establishes charitable foundation
Fast Five Medtech News Podcast
10 minutes 3 seconds
1 year ago
Former Stimwave CEO convicted of healthcare fraud; GE HealthCare establishes charitable foundation
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 14, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Sooma raised $5.5 million for its depression-treating neuromodulation technology. Fast Five hosts Sean Whooley and Danielle Kirsh talk about what the company's technology does and what it plans are for the funds.
SetPoint Medical won FDA breakthrough designation for its nerve stimulation technology for multiple sclerosis. Hear more about the technology and the executives' optimism about the future of the technology.
Abbott is launching its latest Navitor TAVI system in the U.S. Whooley talks about the technology and Abbott's TAVR market history.
GE Healthcare has established a foundation to advance access to healthcare. The Fast Five hosts talk about what the new foundation will focus on and what the future holds.
A former Stimwave CEO was recently convicted of healthcare fraud. Learn more about what the CEO was found guilty of and how the case unfolded.
Fast Five Medtech News Podcast
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 15, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Conformal Medical this week reported "encouraging" results for its left atrial appendage occlusion device. Fast Five hosts Danielle Kirsh and Sean Whooley discuss what the device does and what doctors think about the device.
Autonomix has completed its first procedures in its pancreatic cancer ablation trial. Learn what the trial will assess, what the technology does and how optimistic executives are.
Axonics won CE mark approval for its fourth-generation rechargeable sacral neuromodulation system. Whooley talks about what the device does and some of the other news Axonics has had recently.
SafeGuard Surgical won an FDA breakthrough nod for its biodegradable stent. Hear more about the stent, which has backing from an NFL quarterback.
Edwards reported "excellent" outcomes with its latest Sapien TAVR study. The Fast Five hosts talk about some of the data points that stuck out.
